Streeterville 5-bedroom home with quartz counters: $3.5M
Price: $3,497,747
Listed: March 26, 2025
This five-bedroom, four-and-a-half bath home on the 70th floor of the Residences at Water Tower is a corner unit that was recently rebuilt and offers citywide panorama views through oversized windows. The open format living and dining areas include a foyer, a great room overlooking Lake Michigan and a chef's kitchen. The kitchen is outfitted with Subzero and Wolf appliances, double ovens, a butler's pantry, a wine fridge and an island underneath a mirrored ceiling. The primary suite features a 13-foot walk-in closet and a spa bath with double vanities, a full-height mirror and a soaking tub. All bathrooms have full-slab quartz counters. There is white oak hardwood flooring throughout, in-unit storage and access to the amenities of the Ritz-Carlton Hotel.
Listing agent: Michael Rosenblum, Berkshire Hathaway HomeServices Chicago, 312-286-1634
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNBC
6 days ago
- CNBC
War-weary Syria will be hurt further by Trump's 41% tariff rate — the highest on earth
In May, speaking to a rapt crowd in the Ritz-Carlton Riyadh, U.S. President Donald Trump stunned listeners by announcing he would be ordering the full lifting of U.S. sanctions on Syria, many of which had been in place for decades. "Now, it's their time to shine ... Good luck Syria," Trump said. Less than three months later, the Trump administration hit Syria with the highest tariff rate of any country in the world: 41%. Syria has very little trade with the U.S. because of long-held sanctions, but some trade between the two does exist. In 2023, Syria exported $11.3 million worth of goods to the U.S., according to the Observatory for Economic Complexity, and imported $1.29 million worth of American goods, technically giving the U.S. a trade deficit with the impoverished Middle Eastern country. Trump says the levies his administration imposes — which were based on a widely criticized calculation applied to each country in April using trade deficit figures — are meant to address trade imbalances. He has not commented specifically on the case of Syria. But as it faces the specter of rebuilding its devastated state after 13 years of war under a new government with a very shaky hold on power, the country needs all the help it can get, regional analysts say — not further punishment. "After years of devastating civil war, the country is in urgent need of substantial foreign direct investment to begin the long and difficult process of reconstruction and development," Giorgio Cafiero, CEO of risk consulting firm Gulf State Analytics, told CNBC. "While the recent lifting of many U.S., U.K., and EU sanctions was a welcome development for Damascus' economic ambitions, Washington's imposition of steep tariffs now threatens to restrict any potential for meaningful trade with the United States." Syria had been designated a state sponsor of terrorism by the U.S. government since 1979. U.S. sanctions were imposed on the country in 2004 and again in 2011, after the regime of then-President Bashar Assad launched a brutal crackdown on anti-government uprisings. In the roughly 14 years since, the country has been devastated by civil war, sectarian violence and brutal terrorist attacks, with the Islamic State taking over parts of the country in 2014 and a subsequent Western-led bombing campaign to eradicate the extremist group. The toppling of the Assad regime during a shock offensive by anti-Assad militia groups in December 2024 stunned the global community and brought about the prospect of a new beginning for the devastated country. Syria's new President Ahmed al-Sharaa — a former al-Qaeda member who describes himself as reformed — currently leads the country's transitional government. Syria remained under myriad international sanctions, but those imposed by the U.S. were the most severe, as they applied to third parties as well, deterring other countries and groups from transacting with the country. Most recently, since Trump's official lifting of sanctions in June, Syria has hosted delegations from several countries including the U.S. and wealthy Gulf states pledging support and investment for reconstruction. At the same time, it's been beset by outbursts of sectarian violence in different parts of the country and volleys of Israeli bombings. More than two-thirds of Syria's electricity grid is non-functional, according to aid organizations, with major cities like Aleppo and Damascus facing blackouts for more than 20 hours a day. In many rural and conflict-ridden areas, there is no power at all. "This isn't an economy that is struggling as much as it's an economy that seems to be almost constantly over the last few months, on the verge of collapse, unless very active steps are taken in order to buttress it and give it a chance to recover," said H.A. Hellyer, a senior fellow at the Royal United Services Institute in London. "So any step that deviates from that, I think, is very dangerous." Qatar recently announced a project by which its development fund will purchase gas and provide it to Syria — transported via Azerbaijan and Turkey — to support more than 5 million people, with the expectation of improving daily power supply by as much as 40%. Fahad Al-Sulaiti, the director general of Qatar Fund for Development, described how Damascus will need to lean heavily on aid from Qatar, Saudi Arabia, and the United Nations — particularly now that tariffs will harm the possibility of developing beneficial trade ties with the U.S. He also said Qatar was in close contact with the U.S. government to enable support for Syria. "We work very closely with our partners in the United States. That's why from day one ... we work very close with the Treasury Department ... we're taking with them to create a good economic system," Al-Sulaiti told CNBC. Economic observers note that the 41% tariff itself will have little actual impact on Syria's devastated economy, since bilateral trade between the two countries is so negligible. "But the symbolism behind this decision carries far greater weight than the trade figures suggest," Cafiero said. "The fact that Syria was singled out for the highest tariffs — even after the easing of most sanctions — sends a clear and calculated message from the Trump administration: Washington is willing to loosen its economic grip on a post-regime change Syria, but only under conditions defined by the White House." One interpretation, Cafiero suggested, is that the tariffs could be a way to pressure Damascus into normalizing relations with Israel, which has been attacking and occupying parts of Syria. "In this sense," he said, "the economic policy resembles a kind of 'leash,' designed to be adjusted in response to the political behavior of the al-Sharaa government and broader developments on the ground." Security analysts warn that instability in parts of the country could tip it back into outright war and far greater humanitarian crisis if it does not get the support — economic, humanitarian and diplomatic — that it needs. U.S. envoy to Syria, Tom Barrack, has expressed his and Washington's full support for Syria and the Al Sharaa government, and recently announced U.S. and Qatari-backed investment initiatives into the country. It is not clear whether he supports his administration's imposition of tariffs on the country; the State Department and White House did not respond to CNBC requests for comment. Ultimately, the tariffs themselves may have limited immediate economic consequences, but "their psychological and diplomatic impact should not be underestimated," Cafiero cautioned. "My read is that they reflect Washington's intent to retain leverage over Syria's future."
Yahoo
05-08-2025
- Yahoo
ScaleReady Announces a G-Rex® Grant has been awarded to Sidra Medicine
ST. PAUL, Minn., Aug. 5, 2025 /PRNewswire/ -- ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, today announced that Sidra Medicine, a women and children's hospital in Qatar, has been awarded a $100,000 G-Rex® Grant. Sidra Medicine's G-Rex® Grant will enable expeditious development, validation, and implementation of a G-Rex® centric CAR-T cell production platform. The G-Rex Grant will allow Sidra Medicine to perform the processes and preclinical development for a CD19 CAR-T cell therapy product that will initially be used in pediatric oncology settings. Sidra Medicine will also receive early access to the G-CART™ process currently in development at Cell Ready, the world's first and only G-Rex centric contract development and manufacturing organization (CDMO). The Grant will also support the implementation of fully closed system, semi-automated G-Rex production compliant with current Good Manufacturing Practices (cGMPs). Lastly, the Grant will support the technology transfer to Sidra Medicine's newly established GMP facility for qualification and implementation. "Sidra Medicine is a pioneering healthcare institution that has innovation weaved into the very core of its precision medicine program. Our GMP facility has been specifically set up to develop better treatment protocols for pediatric diseases including cancers, genetic and rare diseases. The G-Rex® Grant will play a key role in accelerating the readiness of our protocols, particularly for Sidra Medicine's pediatric oncology program. Our preliminary findings have already shown us that the G-Rex® method is outstanding in its simplicity and the unique T cell phenotype resulting from the cell culture. This methodology will allow us to implement an affordable, highly efficient G-Rex based cell manufacturing platform with the most suitable T cell phenotype, ultimately having a positive impact on pediatric patient care and cure," said Sara Deola, M.D., Ph.D., Research Investigator at Sidra Medicine. "We're eager to support the emerging Cell & Gene Therapy (CGT) industry in Qatar and the Middle East. By entering the field of CAR-T without any preconceived manufacturing notions and quickly gathering and reviewing G-Rex manufacturing data, Sidra Medicine quickly recognized the full array of advantages that our G-Rex centric manufacturing process offers relative to alternatives. Sidra Medicine's quick grasp of the technical and economic advantages of G-Rex relative to alternatives gives us confidence that this grant will set the stage for low cost and fully scalable CAR-T manufacturing in Qatar and the Middle East." said John Wilson, CEO of Wilson Wolf and co-inventor of G-Rex. ScaleReady's G-Rex Grant Program has now surpassed $40M of no-cost product commitments to grant recipients with the goal of advancing the state of cell and gene-modified cell therapy (CGT) development and manufacturing. Individual Grant Awards are worth up to $300,000. G-Rex Grant Recipients also gain access to exclusive support from ScaleReady's growing consortium of G-Rex Grant Partners who bring best-in-class tools and technologies as well as unparalleled knowledge and expertise in the areas of cGMP manufacturing, quality and regulatory affairs, CGT business operations, and more. Importantly, ScaleReady has just introduced yet another FREE program to accelerate the universal presence of highly efficient and scalable CGT manufacturing. Under this program ScaleReady has partnered with Hanson Wade to launch an event series called LEAN Cell & Gene™. All CGT entities are invited to attend and will learn how to systematically identify and eliminate waste, stabilize business operations, increase drug product quality and supply, and develop a LEAN approach to cell and gene therapy development and manufacturing. For more information about the G-Rex® Grant Program, please contact info@ For more information about LEAN Cell & Gene™, please use this link to register for the free event series. About ScaleReadyScaleReady provides the field of cell and gene-modified cell therapy (CGT) with a G-Rex centric manufacturing platform that enables the world's most practical, flexible, scalable, and affordable CGT drug product development and manufacturing. The G-Rex manufacturing platform is currently used by a rapidly growing list of over 800 organizations and is producing drug products for approximately 50% of CGT clinical trials as well as 5 commercially approved CGT drugs. CGT entities relying on the breadth and scope of ScaleReady's expertise can expect to save years of time and millions of dollars on the path to CGT commercialization. For more information about the ScaleReady G-Rex® Grant Program, please contact info@ About Wilson Wolf ManufacturingWilson Wolf ( is dedicated to simplifying cell and gene-modified cell (CGT) therapy research, process development, and manufacturing. This is being accomplished through its scalable G-Rex technology, which is used throughout the world in CGT applications ranging from basic research to commercial drug production. Wilson Wolf's mission is to create hope for cancer patients, one G-Rex® device at a time. About Bio-Techne CorporationBio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne, in partnership with Wilson Wolf, is creating products such as media and cytokines that are specifically tailored to G-Rex® Bioreactors, including right-sized reagent quantities in containers that are tailored to high throughput closed-system manufacturing. For more information on Bio-Techne and its brands, please visit or follow the Company on social media at: Facebook, LinkedIn, Twitter or YouTube. Contact: David Clair, Vice President, Investor Relations & Corporate About CellReady LLCCellReady is the world's first and only G-Rex centric contract development and manufacturing organization (CDMO) specializing in G-Rex based cell and gene-modified cell therapy development and manufacturing. The company offers a wide range of services to support the development and commercialization of these therapies. CellReady's mission is to create hope for cancer patients, one G-Rex® process at a time. About Sidra Medicine Innovating Care. Transforming Lives From the heart of Qatar, Sidra Medicine, is a private, not-for-profit academic healthcare and research institution for women, children, and young people. Established by the Qatar Foundation for Education, Science, and Community Development, Sidra Medicine is committed to delivering exceptional patient and family-focused care, conducting innovative biomedical and clinical research, and providing a personalized journey of care and cure and precision medicine specifically for rare and genetic diseases. To access our specialised healthcare or international patient services, including pediatric care, women's health, and rare disease treatment or to book a consultation at one of our private clinics, please call +974 40033333 or visit our website at For more information, follow us on Facebook, Instagram, X and LinkedIn. View original content to download multimedia: SOURCE Bio-Techne Corporation
Yahoo
01-08-2025
- Yahoo
An Iconic Lake Winnipesaukee Estate Hits the Market for $13.5 Million
68 & 73 Sewall Road, Wolfeboro, NH — Where Luxury and Legacy Converge WOLFEBORO, N.H., Aug. 1, 2025 /PRNewswire/ -- Nestled along the coveted shores of Lake Winnipesaukee, a once-in-a-generation estate has officially come to market at 68 & 73 Sewall Road in Wolfeboro, New Hampshire. Listed at $13.5 million, this extraordinary waterfront compound spans over 4.5 acres with 247 feet of pristine shoreline, and 14,000+ square feet of combined living space, offering an unmatched blend of historical charm, modern luxury, and lakeside living. Shop Top Mortgage Rates Personalized rates in minutes A quicker path to financial freedom Your Path to Homeownership The primary residence at 68 Sewall Road is a 7,328 square foot waterfront estate, originally built in 1903 and masterfully reimagined to preserve its character while integrating world-class, modern finishes. Highlights include a Christopher Peacock-designed kitchen with a La Cornue range, Sub-Zero appliances, and a light-filled, south-facing dining room that opens to panoramic views of the lake and mountains. Six bedrooms, seven bathrooms, a grand great room, sauna, elevator, a four-season porch, and a state-of-the-art entertainment system complete the main home. A rare two-bay boathouse, fully restored in 2020, features luxurious living quarters above the water—an amenity no longer permitted for new builds. With a heated deck, radiant floor-heated bathroom, and top-of-the-line appliances, it redefines waterfront living. Across the road, 73 Sewall Road adds to the estate's versatility. This quintessential guest house offers four bedrooms, charming cottage aesthetics, and a fully outfitted car barn with lifts, radiant heat, and solar power. Recreational amenities include tennis and basketball courts, and the estate's total combined living space exceeds 14,000 sq ft with 13+ bedrooms and 14+ baths. Situated just half a mile from downtown Wolfeboro—America's oldest summer resort—the estate offers privacy without isolation. Sewall Road is renowned for its prestige, with properties in this enclave known to maintain and grow in value. From luxury finishes to exceptional amenities—and the benefit of no state income tax, no sales tax, and no tax on interest or dividends—this estate offers not just a home, but a lifestyle of unmatched distinction and enduring value. For more information, visit About Adam Dow and The Dow Group Adam Dow is the founder and leader of The Dow Group, New Hampshire's top-producing real estate team from 2015 through 2025. With over $1.5 billion in career sales, Adam and his team are trusted advisors in the luxury real estate market across the state. Known for their market expertise, innovative marketing, and white-glove service, The Dow Group delivers exceptional results for discerning buyers and sellers. To learn more, visit or or follow The Dow Group on Facebook, LinkedIn and Instagram. About PLACEPLACE is the real estate industry's only comprehensive business services and technology platform, designed to support the top real estate teams from any brokerage. From marketing and transaction management to technology and talent solutions, PLACE empowers top producers to scale their businesses efficiently and profitably. To learn more, visit or follow PLACE on Facebook, LinkedIn, and Instagram. View original content to download multimedia: SOURCE PLACE Inc.
